Heron Therapeutics Inc vs Petróleo Brasileiro SA — how do they compare? Heron Therapeutics Inc trades at $0.48 (market cap $91.46M), while Petróleo Brasileiro SA trades at $18.51 (market cap $108.78B). The key difference: Petróleo Brasileiro SA is far larger — about 1189.4× Heron Therapeutics Inc's market cap, and Petróleo Brasileiro SA pays a 9.81% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | PBR | |
|---|---|---|
Market Cap | $91.46M | $108.78B |
Sector | Health | Technology |
52-Week High | $1.96 | $22.03 |
52-Week Low | $0.39 | $11.54 |
Enterprise Value | $189.36M | $171.32B |
Dividend Yield | — | 9.81% |
Trailing returns across standard periods
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →Petróleo Brasileiro S.A., commonly known as Petrobras, is a state-controlled Brazilian multinational corporation in the oil and gas industry. The company is one of the world's largest producers of oil and gas, primarily operating in exploration, production, refining, and power generation. Petrobras is particularly known for its deep-sea and ultra-deep-sea exploration and production activities in the vast pre-salt offshore reserves, which are a major component of Brazil's economy.
Read more on PBR →